WebTMP778 can selectively block mouse Th17 cell differentiation in vitro and impair Th17 cell development in vivo upon immunization with the myelin antigen MOG35-55 plus complete Freund's adjuvant. In addition, TMP778 can repress the expression of more than 150 genes, most of which fall outside the canonical Th17 transcriptional signature and are ... WebTMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations Article Sep 2024 Cancan Lyu So Jin Bing Wambui S...
Jianfei YANG Research profile
WebTMP778 is a novel, potent, and selective RORıt inverse agonist. TMP778 acts potently and selectively to block mouse Th17 cell differentiation in vitro and to impair Th17 cell … WebOct 9, 2024 · Europe PMC is an archive of life sciences journal literature. historic final four
Form T778 - Fill Online, Printable, Fillable, Blank pdfFiller
WebTMP778 is an effective and selective RORγt inverse agonist (IC50: 7 nM in FRET assay). WebAug 14, 2014 · Monoclonal antibodies targeting the IL-23/IL-23R pathway show clinical promise. T helper 17 (Th17) cells have been implicated in the pathogenesis of most common autoimmune diseases, including psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS). WebTMP778 (TMP-778) is a potent, selective RORγt inhibitor with IC50 of 7 nM in FRET assays and 63 nM in IL-17 promoter assays, with no inverse agonist activity. TMP778 blocks human Th17 and Tc17 cell differentiation and also acutely modulates IL-17A production and inflammatory Th17-signature gene expression (IL17a, IL17f, IL22, IL26, CCR6, and IL23) in … honda car service centre near by me